BIO - IPO Update: Avantor Plans $3 Billion U.S. IPO
Quick Take
Avantor (AVTR) has filed to raise $3 billion from an IPO, per an amended registration statement.
The company provides a wide variety of biomedical products and services to research organizations worldwide.
Private equity-owned AVTR will still have a heavy debt load after the IPO and only a low to moderate growth rate
Company & Technology
Radnor, Pennsylvania-based Avantor was founded in 1904 to help enhance production workflow and lower operational costs of companies in the advanced technologies, biopharmaceutical, healthcare, education, government, and applied materials industries.
The firm merged with NuSil in 2016